Cost-benefit analysis Research cagrilintide monotherapy: Cost: $800-1,600/month Weight loss: 10-12% over 68 weeks Total investment: $12,000-24,000 (18 months) Per pound lost (220 lb person, 24 lbs): $500-1,000/lb CagriSema combination: Cagrilintide: $800-1,600/month Semaglutide: $150-300/month Total: $950-1,900/month Weight loss: 15-25% (33-55 lbs for 220 lb person) Total investment: $14,000-28,000 (18 months) Per pound lost: $250-850/lb Better value than monotherapy Comparison to bariatric surgery: Surgery: $15,000-25,000 upfront Weight loss: 25-35% One-time cost Permanent anatomical change CagriSema approaching surgery results without surgery Making it more affordable: Use maintenance doses after titration (lower cost) Consider semaglutide alone initially (cheaper, effective) Add cagrilintide if plateau Budget long-term (12-18 months minimum) Use our peptide cost calculator at SeekPeptides to budget your weight loss protocol accurately
PeptideLabUK.co.uk supplies professionally manufactured research peptides with dependable quality, precision labelling, secure packaging, and dedicated customer support.
About Kyowa Hakko USA (Kyowa) Kyowa Hakko USA serves as the North and South American headquarters for Kyowa Hakko Bio Co., Ltd., a global pioneer in specialty ingredients within Kirin Holdings' Health Science group
A Narrative Review
What GHK-Cu actually is GHK-Cu is a tripeptide composed of three amino acids (glycine, histidine, lysine) bound to a copper ion
- ,
